These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 12393856

  • 1. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.
    Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, Priori S.
    J Clin Invest; 2002 Oct; 110(8):1201-9. PubMed ID: 12393856
    [Abstract] [Full Text] [Related]

  • 2. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S, Veldkamp MW, Stallmeyer B, Baartscheer A, Eckardt L, Paul M, Remme CA, Bhuiyan ZA, Bezzina CR, Schulze-Bahr E.
    PLoS One; 2013 Oct; 8(6):e67963. PubMed ID: 23840796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS, Tranquillo J, Neplioueva V, Bursac N, Grant AO.
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [Abstract] [Full Text] [Related]

  • 7. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR, Sampson KJ, Kateriya S, Glaaser IW, Malito DL, Chung WK, Kass RS.
    Channels (Austin); 2007 Jan; 1(4):273-80. PubMed ID: 18708744
    [Abstract] [Full Text] [Related]

  • 8. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI, Acharfi S, Delacrétaz E, Benammar N, Rotter M, Pfammatter JP, Fressart V, Guicheney P, Chahine M.
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
    Smits JP, Blom MT, Wilde AA, Tan HL.
    Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
    [Abstract] [Full Text] [Related]

  • 12. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS, Verkerk AO, Bhuiyan ZA, Wilde AA, Tan HL.
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG, Nuss HB, Johns DC, Marbán E, Tomaselli GF, Balser JR.
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cardiac sodium channel: gating function and molecular pharmacology.
    Balser JR.
    J Mol Cell Cardiol; 2001 Apr; 33(4):599-613. PubMed ID: 11273715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.